Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #FDA Approval #Clinical Data #Cancer #Quarterly Results #Novo Nordisk

Category: Research

Microscopy News Research

Innovative microscopy traces amyloid beta’s underlying structure for neurodegenerative disease research

  • By Journal Updates
  • 21 July 2024
amyloid beta protein structure

Researchers can now discern orientation and other minute characteristics in the nanostructures of biological systems that were previously unseen thanks to a new imaging technology developed by the Lew lab.

Tagged Amyloid Beta Structure, Protein Structure
Research

Discovery of bacteria that can destroy Forever Chemicals

  • By Editor's Desk
  • 20 July 2024
antibiotic resistant bacteria

Per- and polyfluoroalkyl substances, or PFAS, are another name for forever chemicals. These compounds persist in the environment because of their strong carbon-fluorine chemical interactions.

Tagged Bacteria, Forever Chemicals
Healthcare & Pharmaceuticals News Research

New antibody therapy to neutralize a wide variety of HIV-1 strains

  • By Editor's Desk
  • 19 July 2024
hiv antibody therapy

This new study offers a broadly useful technique to improve nanobodies’ performance. Artificially created antibody fragments, known as nanobodies, are around 10 times smaller than regular antibodies.

Tagged Antibody Therapy, HIV
Gene Therapy News Research

Researchers discovered a new Gene Therapy for muscular dystrophy

  • By Editor's Desk
  • 18 July 2024
gene editing tool

The protein dystrophin, absent in people with muscular dystrophy, will subsequently begin to be produced by the additional genetic code.

Tagged Gene Therapy, Muscular Dystrophy
Research News

Research: A new neural biomarker for OCD

  • By Editor's Desk
  • 14 July 2024
alzheimer's treatments and therapies

Two to three per cent of people worldwide suffer from OCD, a prevalent and debilitating mental illness. OCD affects over two million people in the United States.

Tagged Neural Biomarker, OCD
Gene Therapy News Research

Cystic Fibrosis mutation in human lung cells corrected by Prime Editing

  • By Editor's Desk
  • 11 July 2024
cystic fibrosis in the lungs

Researchers at the University of Iowa, the Broad Institute of MIT, Harvard, and Harvard have now created a gene-editing method that effectively fixes the most prevalent mutation affecting 85% of patients

Tagged Cystic Fibrosis, Lungs
Cancer Research

New research suggests an improved method for the detection of thyroid cancer

  • By Editor's Desk
  • 8 July 2024
how to detect thyroid cancer

The study investigated if cancer status differed according to individuals’ RAS genetic variations.

Tagged Cancer, Thyroid Cancer
Cancer Research

Researchers have developed a groundbreaking method for the scalable synthesis of Withanolides, which inhibits cancer growth

  • By Journal Updates
  • 1 July 2024
withanolides

One of the novel synthesis’s key features is a bioinspired photooxygenation-allylic hydroperoxide rearrangement sequence that makes it easier to add functional groups in the synthesis’s final stages.

Tagged Cancer, Cancer Research, Withanolides
Astrobiology News Research

Phosphate findings in NASA’s OSIRIS-REx samples

  • By Editor's Desk
  • 29 June 2024
nasa asteroid bennu

Bennu is home to the primordial materials that gave rise to our solar system, according to the OSIRIS-REx Sample Analysis Team.

Tagged Biotechnology, OSIRIS-REx mission
Healthcare & Pharmaceuticals News Research

Advancement in research improves checkpoint inhibitor therapy for cancer

  • By Editor's Desk
  • 27 June 2024
gene expression regulation in cancer representation

Researchers at Scripps Research have recently discovered that when taken with checkpoint inhibitors, the immunosuppressive medication ruxolitinib, which is licenced, enhanced T-cell responses and increased the drugs’ ability to fight cancer.

Tagged Cancer, Cancer Therapy

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

IQVIA Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
Technology Healthcare & Pharmaceuticals News

IQVIA Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

22 August 202623 August 2026
BiotechReality Business Intelligence Desk
Moderna With MSD Announces Intismeran KEYTRUDA Melanoma Trial Hits Phase 3 Endpoints
Clinical Trials Clinical Data Healthcare & Pharmaceuticals News

Moderna With MSD Announces Intismeran KEYTRUDA Melanoma Trial Hits Phase 3 Endpoints

21 August 202622 August 2026
Clinical Trials & Data Desk
Genentech Hillsboro Manufacturing Expansion: Roche Subsidiary to Invest $750 Million in New Oregon Device-Fill Facility
Business Healthcare & Pharmaceuticals Manufacturing News

Genentech Hillsboro Manufacturing Expansion: Roche Subsidiary to Invest $750 Million in New Oregon Device-Fill Facility

20 August 202621 August 2026
BiotechReality Business Intelligence Desk
BioMarin Alesta Therapeutics Acquisition: BioMarin Acquires Alesta to Secure Oral HPP Candidate ALE1 for $275M Upfront
Merger & Acquisitions Business Healthcare & Pharmaceuticals News

BioMarin Alesta Therapeutics Acquisition: BioMarin Acquires Alesta to Secure Oral HPP Candidate ALE1 for $275M Upfront

19 August 202619 August 2026
BiotechReality Business Intelligence Desk
AstraZeneca Discontinues Volrustomig Phase III Trial in First-Line Metastatic Non-Small Cell Lung Cancer
Clinical Trials Business Healthcare & Pharmaceuticals Oncology

AstraZeneca Discontinues Volrustomig Phase III Trial in First-Line Metastatic Non-Small Cell Lung Cancer

19 August 202619 August 2026
Clinical Trials & Data Desk
Pfizer Valneva Lyme Disease Vaccine Candidate Clears EMA Application Review Milestone
Regulatory Clinical Data Healthcare & Pharmaceuticals News

Pfizer Valneva Lyme Disease Vaccine Candidate Clears EMA Application Review Milestone

17 August 202617 August 2026
Regulatory Intelligence Desk
Advertisement
BiotechReality JobFinder

  • Product Marketing Data Analyst – Pall (Danaher)
    23 August 2026
  • Financial Analyst, FP&A – Cytiva
    16 August 2026
  • Field Service Account Manager – Bausch+Ströbel
    15 August 2026
  • Process Technician – Roche
    12 August 2026
  • Unified Experience Agentic Platform Product Manager – Eli Lilly and Company
    8 August 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter